Drugs and pharmaceutical electronic market information tool (eMIT)

AI Summary

The provided document outlines the functionality and purpose of the Electronic Market Information Tool (eMIT), which provides essential data regarding pharmaceutical procurement for NHS hospitals in England. The tool provides a comprehensive overview of hospital-sector annual usage estimates for various medicinal products based on data collected from English trusts. Key metrics featured in the eMIT include the average price paid for selected products over the final four months of the reporting period, excluding Value Added Tax (VAT), alongside a measure of how these average prices have shifted over time. The specific dataset described covers a twelve-month reporting cycle ending in June 2025. To maintain commercial integrity, the NHS has adjusted the data to ensure the confidentiality of framework agreement prices is preserved. Unlike a standard regulatory inspection report or warning letter, this document does not specify a private company, inspection dates, or regulatory violations. Instead, it operates within the regulatory framework of NHS procurement transparency and market analysis. There are no mandatory corrective actions for external manufacturers mentioned, as the focus is on providing hospital trusts with the information needed to make informed purchasing decisions and monitor market trends across the pharmaceutical sector.